Concorde Clinical Trials
Concorde Medical Group’s Clinical Trials Program is actively recruiting patients for several research trials. Patients who participate in these trials assist in the advancement of medical science, gain access to cutting-edge treatments, may be eligible to receive medications at no cost, and may receive monetary reimbursement for participation
To learn more about any one of the clinical research trials listed below, please contact Research Study Coordinator, Maureen Haskins at 212-889-5544 ext 152 or e-mail: mhaskins @ concordemed dot com.
This trial evaluates the efficacy of 2 doses of oral budesonide with MMX timed-release technology in the treatment of active mild to moderate ulcerative colitis. Patients will be randomized in a 1:1:1:1 manner to budesonide 6 mg, budesonide 9 mg, asacol and placebo. This trial requires a colonoscopy during the screening period and a second colonoscopy at the end of the 2 month trial period.
DiverticulitisHave you ever been treated or hospitalized for an attack of diverticulitis? Do you get recurrent attacks? Clinical experience has shown that if you have had at least one episode of diverticulitis, you may be at risk for more attacks. Currently, there is no established treatment to prevent recurrences of diverticulitis.
A research study is currently underway to explore an investigational drug aimed at limiting the recurrence of diverticulitis attacks. Concorde Medical Group, conveniently located on the east side of Manhattan, is participating in this nationwide study. You may qualify if you are over 18 years old and have had a documented episode of acute diverticulitis in the past 2 years.
Study participants will receive study medication, study-related examinations and laboratory services at no charge.
In This Section
Central Business Office's
Customer Service hours are
Monday-Friday 9AM to 12 Noon
Physician Referral line
Phone: (212) 614-9489
Ask A Provider
Patient Satisfaction Survey
